Also known as: Parcel Therapuetics, Parcel Therapeutics
Next-generation mRNA medicines
Company is active
Event Year: 2024
Company is active
Event Year: 2024
ParcelBio is dedicated to pioneering the future of medicine through the development and delivery of next-generation RNA therapeutics. By focusing on innovative approaches to RNA delivery and formulation, ParcelBio aims to create more effective and targeted treatments for a wide range of diseases. The company is committed to advancing the field of RNA medicine and improving patient outcomes through cutting-edge research and development.
ParcelBio is dedicated to pioneering the future of medicine through the development and delivery of next-generation RNA therapeutics. By focusing on innovative approaches to RNA delivery and formulation, ParcelBio aims to create more effective and targeted treatments for a wide range of diseases. The company is committed to advancing the field of RNA medicine and improving patient outcomes through cutting-edge research and development.
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2024
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2024
Healthcare
Healthcare
Healthcare -> Therapeutics
Healthcare -> Therapeutics
Team size: 5
Hiring: Yes
Team size: 5
Hiring: Yes